Patent · US Active

Formulation of indomethacin

US9522135B2 · kind B2 · utility

1Cited by
37References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 27, 2015
Grant dateDec 20, 2016
Priority date
Expiry dateJul 27, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T428/2982
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to methods for producing particles of indomethacin using dry milling processes as well as compositions comprising indomethacin, medicaments produced using indomethacin in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of indomethacin administered by way of said medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.